Cornerstone Investment Partners’s Lexicon Pharmaceuticals LXRX Stock Holding History

Cornerstone Investment Partners’s Portfolio LXRX Stock Details LXRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$273K	Buy	+113,739	New	+$222K	0.01%	207

Other funds holding LXRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

CLOS

Compagnie Lombard Odier SCmA 1204 Geneva, Switzerland $9.25B AUM 27.04% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

Janney Montgomery Scott Philadelphia, Pennsylvania $51.6B AUM 27.34% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return

SOW

State of Wyoming Cheyenne, Wyoming $989M AUM 52.24% 1-Year Est. Return

Cornerstone Investment Partners's LXRX Position: Q2 2026 in Review

Cornerstone Investment Partners opened a new position in Lexicon Pharmaceuticals (LXRX) in Q2 2026: 113,739 shares worth $273K. The stake represents 0.01% of the portfolio and ranks #207 among its holdings.

51 funds tracked by Wall St. Rank hold LXRX as of Q2 2026.

Cornerstone Investment Partners held 113,739 shares of Lexicon Pharmaceuticals worth $273K as of Q2 2026.
Lexicon Pharmaceuticals was a new Cornerstone Investment Partners position in Q2 2026.
Lexicon Pharmaceuticals made up 0.01% of Cornerstone Investment Partners's portfolio in Q2 2026, its #207 holding.
51 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q2 2026.

Based on Cornerstone Investment Partners's 13F filing for Q2 2026, filed 7 Aug 2026.